Pharmacogenomics and Personalized Medicine
1467 articles
- Classification of Gastrointestinal Drugs for Acid-related Disorders
- The Role of Digital Health Records in Pharmacogenomic Research
- The Impact of Machine Learning on Predicting Antibiotic Resistance Patterns
- The Application of Data Visualization Tools in Pharmacological Data Analysis
- Advances in Stem Cell Technology for Regenerative Medicine Applications
- Applying Bioinformatics to Discover Novel Natural Product-based Drugs
- The Impact of Digital Twins in Personalized Pharmacotherapy Planning
- The Role of Data Mining in Identifying New Therapeutic Targets
- Development of Smart Pills for Real-time Gastrointestinal Monitoring
- Harnessing Big Data Analytics to Improve Clinical Trial Outcomes
- The Impact of Crispr-cas9 Gene Editing on Pharmacology Treatments
- The Role of Enzymatic Activation in Prodrug-induced Adrs
- The Influence of Age and Gender on Adr Mechanisms
- The Contribution of Enzyme Inhibition to Adr Development
- Understanding the Principles of Receptor Agonism and Antagonism
- Application of Bayesian Methods in Pharmacokinetic Data Analysis
- Applying Microdosing in Pharmacokinetic Research and Development
- How to Calculate Area Under the Curve (auc) in Pharmacokinetics
- The Use of Monte Carlo Simulations in Pharmacokinetic Studies
- How to Interpret Plasma Concentration-time Curves in Clinical Settings
- Distinguishing Between Zero and First-order Kinetics in Pharmacokinetics Studies
- Understanding and Applying the Clofibrate Calculation Method for Lipid Management
- Understanding the Role of Metabolic Pathway Saturation in Interaction Types
- The Role of Enzymatic Deficiencies in Predisposing Patients to Specific Adrs
- How Enzyme Polymorphisms Influence the Efficacy and Toxicity of Antidepressants
- The Impact of Age-related Changes in Enzyme Activity on Adr Susceptibility
- How Pharmacokinetic Variability Affects the Incidence of Adrs in Different Populations
- Role of Hla Alleles in Predicting Adrs: A Pharmacogenetic Perspective
- Understanding the Role of Phase I and Phase Ii Metabolism in Adrs
- The Impact of Genetic Polymorphisms on Adr Risk Through Enzyme Variability